Biotech startup Mirxes weighs US$300m Singapore IPO

The Straits Times LogoThe Straits Times1 mo ago

Biotech startup Mirxes weighs US$300m Singapore IPO

Quick Summary AI Powered

June 27, 2022 7:34 PMSINGAPORE (BLOOMBERG) - Mirxes, a Singapore-based biotechnology startup, is weighing an initial public offering (IPO) in the city-state next year that could raise about US$300 million, according to people with knowledge of the matter.

Deliberations are ongoing and Mirxes could decide not to proceed with the offering, said the people.

The company is in discussions with bankers about a potential offering that could value it at over US$1 billion, said the people, who asked not to be identified as the process is private.

More Pictures


Article Details

Category: Economy

Topics: First Worked Million Mirxes Offering People According Startup Year Singapore A*star

Source Website Secure: Yes (HTTPS)

News Sentiment: Positive

Fact Checked: Legitimate

Article Type: News Report

Published On: 2022-06-27, 19:34:44

News Timezone: GMT +8:00

News Source URL:

Language: English

Reading Time: 3 minutes read

Article Length: 370 words

Coverage Area: Singapore

Availability: Desktop Web, Mobile Web

News ID: 16047

View Article Analysis

About The Straits Times

The Straits Times Logo

Main Topics: Economy

Official Website:

Update Frequency: 16 posts per day

Year Established: 1845

Headquarters: Singapore

News Last Updated: 8h ago

Coverage Areas: Singapore

Ownership: Independent Company

Publication Timezone: GMT +8:00

News Language: English

RSS Feed: Available (XML)

Website Security: Secure (HTTPS)

Publisher ID: #25

Publisher Details

BEAMSTART brings you the latest news, jobs, and events from all around the world on startups, technology, and business. Stay updated with industry news, plug-in to exciting events, and discover incredible career opportunities with the world's most innovative companies.

© Copyright 2022 BEAMSTART. All Rights Reserved.